Abstract: The present technology provides compounds as well as compositions including such compounds useful for the treatment of cancers where the compounds are represented by the following formula (I) or a pharmaceutically acceptable salt thereof, wherein M is an alpha-emitting radionuclide.
Abstract: An atomic force microscope includes a cantilever operating in amplitude modulation mode. A controller determines the amplitude of the cantilever oscillation by processing a signal representative of the cantilever motion by square-rooting a signal having a value substantially equal to a sum of a square of the received signal and a squared and phase-shifted version of the received signal. The aforementioned processing, in some implementations is implemented using analog circuit components.
Abstract: With applications such as soft robotics being severely hindered by the lack of strong soft actuators, the invention provides a new soft-actuator material—Electrically Actuated Hydraulic Solid (EAHS) material—with a stress-density that outperforms any known electrically-actuatable material. One type of actuator is fabricated by making a closed cell that acts as highly paralyzed version of a standard paraffin actuator. Each cell exhibits microscopic expansion, which is summed to produce macroscopic motion. The closed cellular nature of the material allows the system to be cut and punctured and still operate. It can be produced in a lab or industrial scale, and can be formed using molding, 3D printing or cutting.
Abstract: An active electronic device that enables bidirectional communication over a single antenna or path is disclosed. The device may be characterized by a forward path (from an input to an antenna port) offering high gain, and a reverse path (to a receiver port) that can be configured as an finite impulse response (“FIR”) filter. An amplifier of the device is disclosed, the amplifier allowing for tuning of output resistance using passive mixers.
Abstract: Disclosed are methods, systems, components, and compositions for cell-free synthesis of glycosylated proteins. The glycosylated proteins may be utilized in vaccines, including anti-bacterial vaccines. The glycosylated proteins may include a bacterial polysaccharide conjugated to a carrier, which may be utilized to generate an immune response in an immunized host against the polysaccharide conjugated to the carrier. The glycosylated proteins may be synthesized in cell-free glycoprotein synthesis (CFGpS) systems using prokaryote cell lysates that are enriched in components for glycoprotein synthesis such as oligosaccharyltransferases (OSTs) and lipid-linked oligosaccharides (LLOs) including OSTs and LLOs associated with synthesis of bacterial O antigens.
Type:
Grant
Filed:
October 22, 2020
Date of Patent:
January 3, 2023
Assignees:
Cornell University, Northwestern University
Inventors:
Michael Christopher Jewett, Jessica Carol Stark, Matthew P. DeLisa, Thapakorn Jaroentomeechai
Abstract: In some implementations, the present solution can determine a first structural vector of a first chemical based on a chemical structure of the first chemical. The system can also determine first target vector of the first chemical based on at least one gene target for the first chemical. The system can use the structural vector and the target vector to generate a toxicity predictor score for the first chemical.
Abstract: Disclosed are methods, systems, components, and compositions for cell-free synthesis of glycosylated carrier proteins. The glycosylated carrier proteins may be utilized in vaccines, including anti-bacterial vaccines. The glycosylated carrier proteins may include a bacterial polysaccharide conjugated to a carrier, which may be utilized to generate an immune response in an immunized host against the polysaccharide conjugated to the carrier. The glycosylated carrier proteins may be synthesized in cell-free glycoprotein synthesis (CFGpS) systems using prokaryote cell lysates that are enriched in components for glycoprotein synthesis such as oligosaccharyltransferases (OSTs) and lipid-linked oligosaccharides (LLOs) including OSTs and LLOs associated with synthesis of bacterial O antigens.
Type:
Grant
Filed:
March 19, 2019
Date of Patent:
December 20, 2022
Assignees:
Northwestern University, Cornell University
Inventors:
Michael Christopher Jewett, Jessica Carol Stark, Matthew P. DeLisa, Thapakorn Jaroentomeechai
Abstract: The invention provides a compound of formula (I): wherein R is as described herein. The invention also provides a process for the preparation of the compound.
Abstract: A computational model may be used to predict targets of a candidate, or predict candidates that interact with a target. A plurality of pairs may be established, each including a candidate and a respective one of a plurality of controls, each of the plurality of controls known to bind with a target. For each pair, values of at least two datatypes of the candidate may be compared to values of the at least two datatypes of the respective one of the plurality of controls in the pair to generate a similarity score for each of the at least two datatypes of each pair. Similarity scores may be converted to likelihood values indicating likelihood that the candidate and the controls have a shared target based on the respective one of the at least two datatypes. Tests may be performed to validate predictions regarding interactivity of candidates and targets.
Abstract: A radio-frequency method for range finding includes modulating a reference signal having an intermediate frequency to a downlink signal having a carrier frequency using a clock signal. The downlink signal is transmitted to a tag using a transceiver. An uplink signal backscattered from the tag is received and demodulated using the clock signal. The uplink signal has a frequency that is a harmonic of the carrier frequency. A distance between the tag and the transceiver is calculated based on a phase of the demodulated uplink signal. A system for range finding includes a transceiver and a processor. The transceiver modulates a reference signal to a downlink signal and transmits the downlink signal. The transceiver receives and demodulates an uplink signal. The processor is configured to receive the demodulated uplink signal and calculate a distance between the tag and the transceiver using a phase of the demodulated uplink signal.
Abstract: III-Nitride heterostructures with low p-type sheet resistance and III-Nitride heterostructure devices with gate recess and devices including the III-Nitride heterostructures are disclosed.
Type:
Grant
Filed:
November 6, 2019
Date of Patent:
December 6, 2022
Assignee:
Cornell University
Inventors:
Samuel James Bader, Reet Chaudhuri, Huili Grace Xing, Debdeep Jena
Abstract: The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer, an adrenal cortical cancer, a cervical carcinoma, a vulvar carcinoma, an endometrial carcinoma, a primary ovarian carcinoma, a metastatic ovarian carcinoma, a non-small cell lung cancer, a small cell lung cancer, a bladder cancer, a colon cancer, a primary, gastric adenocarcinoma, a primary colorectal adenocarcinoma, a renal cell carcinoma, and/or a prostate cancer.
Type:
Grant
Filed:
September 9, 2020
Date of Patent:
November 15, 2022
Assignee:
Cornell University
Inventors:
John W. Babich, James M. Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala
Abstract: Provided are three dimensional, stretchable, optical sensor networks that can localize deformations. The devices described herein are suitable for uses in soft robots to determine the position of external contact, such as touching, and possibly internal deformations that may be caused by actuation. Sensor networks of the present disclosure contain a substrate, such as a 3D lattice, and cores having a cladding, such as air. Light passes through the cores and upon deformation of the substrate, cores may come into contact, allowing light to couple between cores due to frustrated total internal reflection. The resulting changes in intensity in the cores can be used to determine the placement and magnitude of deformation.
Abstract: The present solution can temporarily impart the handling characteristics of corneal stroma to the otherwise very thin, flimsy, coiling, and fragile Descemet membrane endothelial keratoplasty (DMEK) tissue during its insertion into the anterior chamber and positioning in apposition against the cornea of the recipient eye. The device of the present solution can be configured in a number of ways. In a first configuration, a scaffold can be coupled with the endothelial side of the DMEK graft. In a second configuration, the scaffold can be coupled with the stromal side of the DMEK graft. In a third configuration, one or more scaffolds can be coupled with both the endothelial and stromal side of the DMEK graft.
Abstract: A mechanical vacuum dressing comprising: a first valve layer comprising a first one-way valve; a second valve layer comprising a second one-way valve; the first valve layer being joined to the second valve layer so as to define a chamber therebetween; the first one-way valve being configured to admit fluid into the chamber through the first one-way valve but prevent fluid from exiting the chamber through the first one-way valve; the second one-way valve being configured to exhaust fluid from the chamber through the second one-way valve but prevent fluid from entering the chamber through the second one-way valve; and the second valve layer comprising an elastomeric material such that (i) when the second valve layer is moved away from the first valve layer, the volume of the chamber is increased, and (ii) when the second valve layer is thereafter released, the second valve layer moves back towards the first valve layer and the volume of the chamber is decreased.
Type:
Grant
Filed:
February 22, 2018
Date of Patent:
November 8, 2022
Assignee:
Cornell University
Inventors:
Sang Lee, Anthony Assal, Matthew Baird, John Frederick Cornhill, Russell Corwin, Andrew Harvey, Jeffrey Milsom, Anh Nguyen, Jia Xing, James Goldie, Vladimir Gilman, Minh Duong, Jennifer Vondran, Blair Hough, Gerard I. Libby, Timothy Norman Johnson, Darwin T. Keith-Lucas
Abstract: The technology disclosed in this patent document can be used to implement an optical device for generating broadband optical pulses, including an optical waveguide having different waveguide structures at different locations along the optical waveguide and with varying dimensions or pressure gradient that change adiabatically along the different locations to enable non-linear four wave mixing over a broad spectral range.
Type:
Grant
Filed:
May 14, 2019
Date of Patent:
November 1, 2022
Assignees:
Cornell University, Ramot at Tel-Aviv University LTD
Abstract: The technology disclosed can be implemented to construct devices with an array of optical elements to provide power to stimulate a biological process in a nerve system in living objects, and to provide patterned light outputs from the array of optical elements to indicate a corresponding electrical pattern monitored from the biological process in the nerve system. In one aspect a nerve stimulator apparatus is disclosed including a plurality of optical to electrical transducers arranged in a two-dimensional array, wherein each of the plurality of optical to electrical transducers is configured to convert light to an electrical signal; a plurality of electrodes, each electrode associated with one or more associated optical to electrical transducers; and a plurality of electrical interconnects to connect each of the plurality of electrodes to the one or more associated optical transducers.
Type:
Grant
Filed:
April 15, 2020
Date of Patent:
November 1, 2022
Assignee:
Cornell University
Inventors:
Alejandro J. Cortese, Jesse H. Goldberg, Teja Pratap Bollu
Abstract: Provided are compositions and methods for promoting osteogenic differentiation of undifferentiated cells, such as stem cells. An example of a compound useful in the present method is 6,8-dimethyl-3-(4-phenyl-1H-imidazol-5-yl)quinolin-2(1H)-one (DIPQUO). The present methods can be used for treatment and prevention of bone disorders.
Abstract: The technology disclosed in this patent document can be used to implement an optical coherent tomography (OCT) system that combines a control of the probe light to the target sample with different optical aberration patterns in optically probing the target sample and an OCT imaging processing to enhance the OCT imaging quality by combining image signals from in-phase contributions from the probing with different optical aberration patterns while suppressing randomly phased contributions from scattering by the target sample.
Type:
Grant
Filed:
September 18, 2020
Date of Patent:
October 25, 2022
Assignee:
Cornell University
Inventors:
Steven Adie, Siyang Liu, Michael Lamont
Abstract: Known intra-domain routing methods (e.g., OSPF and IS-IS) are link-state routing protocols with hop-by-hop forwarding that sacrifice optimal traffic engineering for ease of implementation and management. Known optimal traffic engineering procedures are either not link-state methods or require source routing—characteristics that make them difficult to implement. Certain embodiments of the present invention include a fully distributed, adaptive, link-state routing protocol with hop-by-hop forwarding configured to achieve optimal traffic engineering. Such embodiments facilitate significant performance improvements relative to known intra-domain routing methods and decrease network infrastructure requirements.